Ulotaront hydrochloride by Sumitomo Pharma America for Schizophrenia: Likelihood of Approval

Ulotaront hydrochloride is under clinical development by Sumitomo Pharma America and currently in Phase III for Schizophrenia.

Industry groups in California vie for new Medicaid money

California’s powerful health care industry just notched a historic win: The state is going to give it an $11.1 billion infusion to improve care for

July 21, 2023

Training program for health workers aims to reduce the burden of breast cancer in Malawi

Women in rural Malawi are learning how to detect breast cancer thanks to the country’s first dedicated training programme for health workers, aimed at reducing

September 13, 2023

California Medicaid ballot measure is popular, well funded — and perilous, opponents warn

The proponents of Proposition 35, a November ballot initiative that would create a dedicated stream of funding to provide health care for California’s low-income residents,

September 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.